March 2023 - Volume 30 - Issue 3 : Menopause

Secondary Logo

Journal Logo

Advanced Search
March 2023 - Volume 30 - Issue 3
pp: 235-354
Table of Contents Outline
Contributor Index

Efficacy and safety of elinzanetant, a selective neurokinin-1,3 receptor antagonist for vasomotor symptoms: a dose-finding clinical trial (SWITCH-1)

Simon, James A.; Anderson, Richard A.; Ballantyne, Elizabeth; More

Menopause. 30(3):239-246, March 2023.

AntimĂ¼llerian hormone and adiposity across midlife among women in Project Viva

Francis, Ellen C.; Oken, Emily; Hivert, Marie-France; More

Menopause. 30(3):247-253, March 2023.

Menopause hormone therapy and sarcodynapenia: the Canadian Longitudinal Study on Aging

CĂ¢mara, Saionara M. A.; MacĂªdo, Pedro R. S.; Velez, Maria P.

Menopause. 30(3):254-259, March 2023.

Symptom experience during the late reproductive stage versus the menopausal transition in the Spanish-language Women Living Better survey

Cortés, Yamnia I.; Coslov, Nina; Richardson, Marcie K.; More

Menopause. 30(3):260-266, March 2023.

Symptom monitoring improves physical and emotional outcomes during menopause: a randomized controlled trial

Andrews, Robin A. F.; John, Bev; Lancastle, Deborah

Menopause. 30(3):267-274, March 2023.

Network analysis of eating disorder symptoms in women in perimenopause and early postmenopause

Finch, Jody E.; Xu, Ziqian; Girdler, Susan; More

Menopause. 30(3):275-282, March 2023.

Artificially sweetened beverages and urinary incontinence—a secondary analysis of the Women's Health Initiative Observational Study

Ringel, Nancy E.; Hovey, Kathleen M.; Andrews, Chris A.; More

Menopause. 30(3):283-288, March 2023.

Menopausal symptoms in breast cancer patients receiving adjuvant endocrine therapy and their relationships with health-promoting behaviors and social support

Wei, Tingting; Li, Xia; Qiang, Wanmin; More

Menopause. 30(3):289-295, March 2023.

Urban-rural differences in epidemiology and risk factors of menopause syndrome in middle-aged Chinese women

An, Junxia; Li, Lifei

Menopause. 30(3):306-316, March 2023.

Associations between bone mass, hormone levels, and body composition in postmenopausal women

Fighera, Tayane M.; Santos, BetĂ¢nia R.; Motta, LetĂ­cia; More

Menopause. 30(3):317-322, March 2023.

Psychometric properties of a Persian version of the Vulvovaginal Symptoms Questionnaire for measuring vulvovaginal symptoms in postmenopausal women

Shaabani, Niloofar; Parvizi, Mohammad Mahdi; Bagheri, Zahra; More

Menopause. 30(3):323-328, March 2023.

NAMS Practice Pearl

Clinical considerations for menopause and associated symptoms in women with HIV

Looby, Sara E.

Menopause. 30(3):329-331, March 2023.

Endogenous dehydroepiandrosterone and depression in postmenopausal women: a systematic review of observational studies

Hemachandra, Chandima; Davis, Susan R.; Bell, Robin J.; More

Menopause. 30(3):332-340, March 2023.

Use of exogenous hormones in those at increased risk for breast cancer: contraceptive and menopausal hormones in gene carriers and other high-risk patients

Pederson, Holly J.; Batur, Pelin

Menopause. 30(3):341-347, March 2023.

Menopause is associated with increased prevalence of nonalcoholic fatty liver disease: a systematic review and meta-analysis

Jaroenlapnopparat, Aunchalee; Charoenngam, Nipith; Ponvilawan, Ben; More

Menopause. 30(3):348-354, March 2023.